Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

anti-EpCAM monoclonal antibody AM-928

A humanized monoclonal antibody directed against the tumor-associated antigen (TAA) epithelial cell adhesion molecule (Ep-CAM; EpCAM; CD326), with potential antineoplastic activity. Upon administration, anti-EpCAM monoclonal antibody AM-928 targets and binds to EpCAM on EpCAM-expressing tumor cells. This inhibits EpCAM-mediated signaling and the proliferation of EpCAM-expressing tumor cells. EpCAM, a cell surface protein upregulated on many tumor cell types, promotes the proliferation, migration and invasiveness of tumor cells.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Code name:	AM 928 AM-928 AM928

anti-EpCAM monoclonal antibody AM-928

Search NCI's Drug Dictionary